APPLIED GENETIC TECHNOLOGIES CORP Equity Method Investments
APPLIED GENETIC TECHNOLOGIES CORP had Equity Method Investments of $7.73 million as of 2022-09-30, per its 10-Q filed 2022-11-21.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:EquityMethodInvestments · last filed 2022-11-21
- 2022-09-30: Equity Method Investments $7.73M.
- 2022-06-30: Equity Method Investments $7.81M.
- 2022-03-31: Equity Method Investments $7.88M.
- 2021-12-31: Equity Method Investments $7.94M.
| Period end | Equity Method Investments |
|---|---|
| 2022-09-30 | $7.73M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $7.81M 10-Q · filed 2022-11-21 |
| 2022-03-31 | $7.88M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $7.94M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $7.97M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $8.00M 10-K · filed 2022-09-27 |
| 2021-03-31 | $8.02M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $8.05M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $8.07M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $8.10M 10-K · filed 2021-09-23 |
| 2020-03-31 | $8.12M 10-Q · filed 2020-05-13 |
| 2019-06-30 | $1.95M 10-K · filed 2020-09-18 |
| 2018-03-31 | $2.00M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $2.00M 10-Q · filed 2018-02-09 |
| 2017-06-30 | $2.00M 10-Q · filed 2018-05-08 |